TABLE 5.
Prevalence of Pancreatic Cancer in Melanoma-prone Families for 10 Pathogenic CDKN2A Variants
| No. Families | Variant* | No. Families With a Member Affected With PDAC |
|---|---|---|
| 21 | p.A76fs | >60% |
| 19 | p.M53I | <11% |
| 16 | p.G101W | 35% to 50% |
| 11 | p.R112_L113insR | >60% |
| 11 | c.−34G>T | 15% to 25% |
| 11 | c.IVIS2–105A>G | <11% |
| 9 | p.R24P | 15% to 25% |
| 7 | p.V126D | 35% to 50% |
| 6 | p.L32P | 35% to 50% |
| 6 | c.32_33ins9–32 | <11% |
Variant position given in reference to NP_000068.1 for protein change (p.) and NM_000077.4 for transcript change (c.). PDAC – pancreatic adenocarcinoma.